Tacrolimus-induced neutropenia in renal transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 690-694

  De Rycke, Anja ^a   Dierickx, Daan ^a   Kuypers, Dirk R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TACROLIMUS;

ADULT; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MALE; NEUTROPENIA; SHORT SURVEY;

CYCLOSPORINE; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUTROPENIA; SEVERITY OF ILLNESS INDEX; TACROLIMUS;

EID: 79953004065     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07320810     Document Type: Short Survey

References (10)

1. Zafrani L, Truffaut L, Kreis H, Etienne D, Rafat C, Lechaton S, Anglicheau D, Zuber J, Ciroldi M, Thervet E, Snanoudj R, Mamzer MF, Martinez F, Timsit MO, Bergougnoux L, Legendre C: Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: A retrospective study. Am J Transplant 9: 1816-1825, 2009
2. Scott LJ, McKeage K, Keam SJ, Plosker GL: Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 63: 1247-1297, 2003 (Pubitemid 36750952)
3. Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC: Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomized trial data. BMJ 331: 810, 2005
4. Dobrolet NC, Webber SA, Blatt J, Michaels M, Kiaffas M, Kurland G, Boyle GJ: Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant 5: 125-131, 2001 (Pubitemid 32298573)
5. Hirao A, Kawano Y, Takaue Y: Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. Blood 81: 1179-1183, 1993 (Pubitemid 23067353)
6. Koenig JM, Matharoo N, Stegner JJ, Schowengerdt KO: Tacrolimus: In vitro effects on myelopoiesis, apoptosis, and CD11b expression. J Heart Lung Transplant 24: 1332-1336, 2005
7. Zucker K, Tsaroucha A, Olson L, Esquenazi V, Tzakis A, Miller J: Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther Drug Monit 21: 35-43, 1999 (Pubitemid 29077452)
8. Kuypers DR, Vanrenterghem Y, Squifflet JP, Mourad M, Abramowicz D, Oellerich M, Armstrong V, Shipkova M, Daems J: Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit 25: 609-622, 2003 (Pubitemid 37238896)
9. Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346: 995-1008, 2002
10. Andrès E, Maloisel F, Zimmer J: The role of hematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis. Br J Haematol 150: 3-8, 2010